Danyelza 73042-0201
Generic: Naxitamab
Product NDC
73042-0201- Manufacturer
- Y-Mabs Therapeutics, Inc.
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 25, 2020
- Listing Expires
- December 31, 2026
- Application
- BLA761171
Need to source Danyelza? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Naxitamab | 40 mg/10mL |
Drug Class
Glycolipid Disialoganglioside-directed Antibody [EPC]Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]Glycolipid Disialoganglioside-directed Antibody [EPC]
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (73042-201-01) / 10 mL in 1 VIAL, SINGLE-DOSE